Search

Your search keyword '"Lonn E"' showing total 293 results

Search Constraints

Start Over You searched for: Author "Lonn E" Remove constraint Author: "Lonn E" Publication Type Academic Journals Remove constraint Publication Type: Academic Journals
293 results on '"Lonn E"'

Search Results

2. Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial

3. Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial

6. Common carotid intima-media thickness does not add to Framingham risk score in individuals with diabetes mellitus: the USE-IMT initiative

11. Baseline characteristics of patients in the Reduction of Events with Darbepoetin alfa in Heart Failure trial (RED-HF)

21. Low resting heart rates are associated with new-onset atrial fibrillation in patients with vascular disease: results of the ONTARGET/ TRANSCEND studies.

22. Resting heart rate is associated with renal disease outcomes in patients with vascular disease: results of the ONTARGET and TRANSCEND studies.

23. The antioxidant vitamins and cardiovascular disease. A critical review of epidemiologic and clinical trial data.

28. Effects of ramipril and rosiglitazone on cardiovascular and renal outcomes in people with impaired glucose tolerance or impaired fasting glucose: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial.

29. Cardiac Function Stratification Based on Echocardiographic or Clinical Markers of Left Ventricular Filling Pressures Predicts Death and Hospitalization Better Than Stratification by Ventricular Systolic Function Alone.

32. Homocysteine-lowering therapy and risk for venous thromboembolism: a randomized trial.

33. Diastolic dysfunction in heart failure with preserved systolic function: need for objective evidence:results from the CHARM Echocardiographic Substudy-CHARMES.

36. Serum potassium, cardiovascular risk, and effects of an ACE inhibitor: results of the HOPE Study.

47. Carotid artery intima-media thickness--a new noninvasive gold standard for assessing the anatomic extent of atherosclerosis and cardiovascular risk?

50. Dose response of ACE inhibitors: implications of the SECURE trial

Catalog

Books, media, physical & digital resources